Pharmacokinetic and Safety Study of Metronidazole Oral Suspension in Pediatric Patients With Anaerobic Bacterial Infection
Part of paid clinical trials in Miami, Florida.
- Sponsor
- Saptalis Pharmaceuticals LLC
- Study ID
- NCT07146217
- Phase
- PHASE2
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Bacterial Infections
Eligibility Criteria
- Sex
- ALL
- Age
- 12 Months - 4 Years
- Healthy Volunteers
- Not accepted
Interventions
- Likmez® (metronidazole) Oral Suspension — DRUGEach patient will receive 7.5 mg/kg of Likmez® every 6 hours, with a concentration of 100 mg metronidazole/mL
Study Details
This is an open-label, single-arm, pharmacokinetic and safety study of Likmez® in pediatric patients aged 12 months to \<4 years with anaerobic bacterial infection
Key Dates
- Start date
- Aug 31, 2025
- Status verified
- Aug 2025
- Primary completion
- Jul 31, 2026
- Completion
- Oct 31, 2026
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Likmez® (metronidazole) Oral Suspension
Primary Outcome Measure
Maximum plasma concentration [Cmax] [ Time Frame: Day 1 at Pre-dose (0.00 hour, within 01 hour prior to dosing) and at 01.00, 02.00, 4.00 and 6.00 hours post-dose ]
Central Contacts
- Santhy John631-231-2751
- Veera Somasani631-231-2751
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Bioresearch Partner | Miami | Florida | 33155 | Suzelle Costales Dr.Octavio Carreno (PRINCIPAL_INVESTIGATOR) |
| Empire Medical Clinical Trials | Miami | Florida | 33183 | Yovanny Blanco Martin Francisco Garrido (PRINCIPAL_INVESTIGATOR) |
| Aavon Clinical Trials | Richmond | Texas | 77407 | Prashant Zanzane Vinita Chandwani (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Miami, FL
Related Studies
- A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin LymphomaPHASE3 · Recruiting · Grifols Therapeutics LLC · Huntington Park, California
- A Study to Investigate Safety and Pharmacokinetics of Intravenous Cefiderocol/Xeruborbactam in Participants With Renal ImpairmentPHASE1 · Recruiting · Qpex Biopharma, Inc. · Miami, Florida
- [18F]Fluoropropyl-Trimethoprim ([18F]F-TMP) PET/CT Imaging to Evaluate Biodistribution and Kinetics in Human SubjectsPHASE1 · Recruiting · University of Pennsylvania · Philadelphia, Pennsylvania
- Large Algorithm Setting and Validation StudyNot Yet Recruiting · Nanopath, Inc · New Orleans, Louisiana